Skip to Main Content

Paper Details

3'-[<sup>18</sup>F]fluoro-3'-deoxythymidine ([<sup>18</sup>F]FLT) Positron Emission Tomography as an In Vivo Biomarker of inhibition of CDK 4/6-Rb pathway by Palbociclib in a patient derived bladder tumor.
J Transl Med
1
2022
3'-[F]fluoro-3'-deoxythymidine, 4, CDK, CDK4, CDK4/6, PDX, Palbociclib, Rb, [F]FLT, bladder tumor, breast cancer, cancer, mice, non-breast cancer model, palbociclib, patient, solid tumors, temozolomide, tumor, tumors
Author NameAffiliation
James H DoroshowNational Cancer Institute, National Institutes of Health
James H DoroshowNational Cancer Institute, National Institutes of Health
  • 1 - 2

Datasets

Release 1.2